WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007005738) GLP-1 PHARMACEUTICAL COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/005738    International Application No.:    PCT/US2006/025826
Publication Date: 11.01.2007 International Filing Date: 30.06.2006
IPC:
C07K 14/605 (2006.01)
Applicants: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. [FR/FR]; 51, 53 Rue Du Docteur Blanche, F-75016 Paris (FR) (For All Designated States Except US).
DONG, Zheng, Xin [US/US]; (US) (For US Only).
CHERIF-CHEIKH, Roland [FR/ES]; (ES) (For US Only).
CORDERO RIGOL, Jose-Antonio [ES/ES]; (ES) (For US Only).
ALLOZA MIRAVETE, Resurreccion [ES/ES]; (ES) (For US Only).
LACOMBE, Frederic [FR/ES]; (ES) (For US Only).
TOBALINA MAESTRE, Maria, Dolores [ES/ES]; (ES) (For US Only)
Inventors: DONG, Zheng, Xin; (US).
CHERIF-CHEIKH, Roland; (ES).
CORDERO RIGOL, Jose-Antonio; (ES).
ALLOZA MIRAVETE, Resurreccion; (ES).
LACOMBE, Frederic; (ES).
TOBALINA MAESTRE, Maria, Dolores; (ES)
Agent: MORRILL, Brian, R.; BIOMEASURE, INCORPORATED, 27 Maple Street, Milford, MA 01757-3650 (US)
Priority Data:
60/696,142 30.06.2005 US
Title (EN) GLP-1 PHARMACEUTICAL COMPOSITIONS
(FR) COMPOSITIONS PHARMACEUTIQUES DE GLP-1
Abstract: front page image
(EN)The present invention is directed to peptide analogues of glucagon-like peptide-1 , the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
(FR)L'invention concerne des analogues peptidiques du peptide analogue du glucagon GLP-1, les sels pharmaceutiquement acceptables de ceux-ci, des méthodes d'utilisation de ces analogues pour le traitement de mammifères, et des compositions pharmaceutiques destinées à ces traitements, contenant lesdits analogues.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)